Syntiron LLC, sanofi-aventis deal

Syntiron granted sanofi-aventis' Sanofi Pasteur S.A. vaccines division exclusive, worldwide rights to develop and commercialize Syntiron's vaccine against Staphylococcus aureus. The companies will col...